naringenin has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmedy, OA; Ibrahim, SM; Salem, HH; Sayed, NH | 1 |
| Cham, TM; Lin, CC; Lin, LT; Wu, TH; Yen, FL | 1 |
2 other study(ies) available for naringenin and Acute Hepatic Failure
| Article | Year |
|---|---|
Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Autophagy; Beclin-1; Caspase 3; Disease Models, Animal; Flavanones; Galactosamine; Humans; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Microtubule-Associated Proteins; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Superoxide Dismutase-1; Tumor Suppressor Protein p53 | 2022 |
Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.
Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Caspases; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Enzyme Activation; Flavanones; Lipid Peroxidation; Liver; Liver Failure, Acute; Male; Nanoparticles; Oxidative Stress; Particle Size; Polymethacrylic Acids; Polyvinyl Alcohol; Rats; Rats, Wistar; Solubility; Surface Properties; Technology, Pharmaceutical | 2009 |